Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick Allanore

Showing results (231-240 of 493) with videos related to

Pageof 50
Sort By:
Arthritis Care & Research|October 27, 2017
Prevalence and Disease-Specific Risk Factors for Lower Urinary Tract Symptoms in Systemic Sclerosis: An International Multicenter StudyGregor John, Jérôme Avouac, Silvia Piantoni, et al.
Rheumatology (Oxford, England)|February 8, 2018
Factors influencing early referral, early diagnosis and management in patients with diffuse cutaneous systemic sclerosisOliver Distler, Yannick Allanore, Christopher P Denton, et al.
The Journal of Rheumatology|September 3, 2010
Limited value of temporal artery ultrasonography examinations for diagnosis of giant cell arteritis: analysis of 77 subjectsCarla Maldini, Caroline Dépinay-Dhellemmes, Thi T S Tra, et al.
Joint Bone Spine|July 23, 2023
Comparison of subcutaneous and oral methotrexate initiation in rheumatoid arthritis in current practicePaola Vidal-Montal, Marion Thomas, Alice Combier, et al.
Rheumatology International|September 13, 2017
An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud's phEnomenon (SUNSHINE survey)Francesca Ingegnoli, Nicola Ughi, Graham Dinsdale, et al.
Thorax|October 27, 2011
Alveolar concentration of nitric oxide predicts pulmonary function deterioration in sclerodermaKiet Phong Tiev, Thong Hua-Huy, Adrien Kettaneh, et al.
The Lancet. Rheumatology|January 17, 2024
Comparative efficacy and safety of treatments for secondary Raynaud's phenomenon: a systematic review and network meta-analysis of randomised trialsCharles Khouri, Marion Lepelley, Sebastien Bailly, et al.
Arthritis and Rheumatism|July 9, 2003
Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacyJacques-Eric Gottenberg, Florence Merle-Vincent, Fabrice Bentaberry, et al.
International Journal of Cardiology|August 21, 2016
N-terminal pro-brain natriuretic peptide is a strong predictor of mortality in systemic sclerosisYannick Allanore, Andras Komocsi, Serena Vettori, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 10, 2019
Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung DiseaseMuriel Elhai, Anna Maria Hoffmann-Vold, Jérôme Avouac, et al.
Pageof 50

Showing results (231-240 of 493) with videos related to

Sort By:
Pageof 50
Arthritis Care & Research|October 27, 2017
Prevalence and Disease-Specific Risk Factors for Lower Urinary Tract Symptoms in Systemic Sclerosis: An International Multicenter StudyGregor John, Jérôme Avouac, Silvia Piantoni, et al.
Rheumatology (Oxford, England)|February 8, 2018
Factors influencing early referral, early diagnosis and management in patients with diffuse cutaneous systemic sclerosisOliver Distler, Yannick Allanore, Christopher P Denton, et al.
The Journal of Rheumatology|September 3, 2010
Limited value of temporal artery ultrasonography examinations for diagnosis of giant cell arteritis: analysis of 77 subjectsCarla Maldini, Caroline Dépinay-Dhellemmes, Thi T S Tra, et al.
Joint Bone Spine|July 23, 2023
Comparison of subcutaneous and oral methotrexate initiation in rheumatoid arthritis in current practicePaola Vidal-Montal, Marion Thomas, Alice Combier, et al.
Rheumatology International|September 13, 2017
An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud's phEnomenon (SUNSHINE survey)Francesca Ingegnoli, Nicola Ughi, Graham Dinsdale, et al.
Thorax|October 27, 2011
Alveolar concentration of nitric oxide predicts pulmonary function deterioration in sclerodermaKiet Phong Tiev, Thong Hua-Huy, Adrien Kettaneh, et al.
The Lancet. Rheumatology|January 17, 2024
Comparative efficacy and safety of treatments for secondary Raynaud's phenomenon: a systematic review and network meta-analysis of randomised trialsCharles Khouri, Marion Lepelley, Sebastien Bailly, et al.
Arthritis and Rheumatism|July 9, 2003
Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacyJacques-Eric Gottenberg, Florence Merle-Vincent, Fabrice Bentaberry, et al.
International Journal of Cardiology|August 21, 2016
N-terminal pro-brain natriuretic peptide is a strong predictor of mortality in systemic sclerosisYannick Allanore, Andras Komocsi, Serena Vettori, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 10, 2019
Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung DiseaseMuriel Elhai, Anna Maria Hoffmann-Vold, Jérôme Avouac, et al.
Pageof 50